GIC Housing Finance provides home loans and related financial services to individual borrowers and employees of its promoter insurance companies across India, earning income through interest spreads and insurance commissions.
The company lacks a durable moat as evidenced by stagnant revenue and EPS growth over the period. While it has a scale advantage through its promoter network, the ROCE of 8.8% is below the typical cost of equity for Indian financial firms, indicating no significant competitive advantage.
Capital is primarily deployed into the retail loan book with a consistent dividend payout ratio of approximately 15-16%. However, the lack of growth in EPS and revenue suggests that reinvested earnings are not generating incremental value for shareholders.
Over five years, the company's thin interest coverage of 1.23 left no room for error as borrowing costs rose, while the stagnant revenue growth turned into a slow contraction. The high leverage of 4.33x acted as a lead weight, and the negative cash conversion cycle eventually forced a liquidity crunch. As impairment charges continued to climb—already showing a fourfold increase in recent filings—the book value was eroded by credit losses that the meager 8.8% ROCE could not outpace, resulting in a permanent impairment of capital.
RichFakir rates GIC Housing Finance Ltd's business quality as poor — 47/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, GIC Housing Finance Ltd is trading about 46% below our estimate of fair value; we rate its price cheap. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on GIC Housing Finance Ltd is: Not rated. A poor business at a cheap price — it does not make our shortlist right now. We marked it down a notch: revenue and earnings barely grow — a steady cash cow, not a compounder.
RichFakir's educational estimate of GIC Housing Finance Ltd's fair value is about ₹224 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →